14.49
-0.3054(-2.06%)
Currency In USD
| Previous Close | 14.8 |
| Open | 14.84 |
| Day High | 14.98 |
| Day Low | 14.36 |
| 52-Week High | 27.13 |
| 52-Week Low | 11.06 |
| Volume | 679,090 |
| Average Volume | 1.23M |
| Market Cap | 1.13B |
| PE | -2.22 |
| EPS | -6.54 |
| Moving Average 50 Days | 14.15 |
| Moving Average 200 Days | 17.39 |
| Change | -0.31 |
If you invested $1000 in Integra LifeSciences Holdings Corporation (IART) 10 years ago, it would be worth $490.59 as of October 06, 2025 at a share price of $14.495. Whereas If you bought $1000 worth of Integra LifeSciences Holdings Corporation (IART) shares 5 years ago, it would be worth $296.96 as of October 06, 2025 at a share price of $14.495.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
GlobeNewswire Inc.
Sep 22, 2025 12:30 PM GMT
Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice Dr. Raymond Turner Dr. Turner joins Integra LifeSciences as chief medical officer PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) --
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
GlobeNewswire Inc.
Aug 29, 2025 8:30 PM GMT
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knigh
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
GlobeNewswire Inc.
Jul 14, 2025 8:35 PM GMT
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the ma